- Adjunct Professor, Johns Hopkins University, 2011-present
- Senior Investigator and Section Chief, NIDDK, NIH, 2005-present
- Director, the NIH/Johns Hopkins University Graduate Partnership Program, NIH, 2008-2016
- Tenure-Track Investigator, NIDDK, NIH, 1998-2005
- Postdoctoral Fellow, The Carnegie Institution of Washington, 1994-1998
- Ph.D., Weizmann Institute of Science, 1994
- M.S., Weizmann Institute of Science, 1989
- B.A., Tel-Aviv University, 1986
The ultimate goal of our research is to understand basic processes that contribute to nuclear morphology and to elucidate the relationship between nuclear structure and nuclear function.
The main research focus of my lab is the relationship between nuclear structure and nuclear function. Altered nuclear shape is observed in certain types of disease, such as cancer, and during aging. However, the relationship between changes to nuclear morphology and either disease state or aging is unknown. Moreover, in many cell types, there is a constant ratio between nuclear volume and cell volume. How this ratio is established and what is its importance to normal cell function are unknown. Finally, there are many basic questions related to nuclear structure and function that remain to be answered. For example, how does the nuclear envelope form at the end of mitosis? What dictates the formation of a single nucleus that encompasses all chromosomes rather than multiple nuclei that contain a subset of chromosomes? How does the nuclear envelope expand? Since the nuclear envelope is continuous with the endoplasmic reticulum (ER), what role does the ER play in nuclear morphology? How does the nuclear envelope contribute to the intra-nuclear organization of chromosome domains and how does nuclear morphology affect processes such as DNA replication, transcription, splicing, and repair of DNA damage? Given the link between pathology and nuclear morphology, we expect that gaining insight into the proteins and processes that affect nuclear shape will lead to a better understanding of disease progression, diagnostics, prevention, and treatment.
In order to uncover proteins and processes that contribute to nuclear structure and integrity, we are conducting genetic screens in budding yeast and C. elegans for mutations or conditions that alter nuclear shape. For example, we found that lipid biosynthesis plays an important role in maintaining nuclear shape in both yeast and in C. elegans. We also discovered that in yeast cells, which undergo closed mitosis (i.e., without nuclear envelope breakdown), a mitotic delay results in altered nuclear shape in a specific region of the nuclear envelope. This observation raises the possibility that at least in yeast, the nuclear envelope is not homogenous; rather, it has distinct domains that are capable of expanding. Moreover, we found that nuclear envelope expansion is independent of cell size, suggesting that one or more complnents of the nucleoplasm determines nuclear size. Studies are underway to determine what regulates yeast nuclear envelope expansion, what defines nuclear envelope domains, what determines nuclear size, and how various mutants that alter nuclear shape contribute to nuclear morphology and nuclear function.
We also conducted a systematic RNA interference screen in C. elegans to identify additional genes and pathways that contribute to nuclear shape and function. We currently have a large number of genes that, when down-regulated, affect nuclear structure and these fall into various functional categories—some of which are quite surprising, such as RNA processing, ribosome biogenesis, and protein transport. We are currently investigating the mechanisms by which these genes affect nuclear organization and nuclear function.
One group of C. elegans genes that is of particular interest to us includes genes that when down regulated prevent the mixing of parental genomes after fertilization. We showed that polo-like kinase PLK-1 is necessary for breaching the nuclear envelopes of the maternal and paternal pronuclei after pronuclear meeting in order to allow the two parental genomes to mix. We are currently investigating how these nuclear membranes are breached.
Applying our Research
Alteration in nuclear shape and size is associated with cancer and aging. While we don’t know how nuclear shape is linked to disease, it is likely that changes in nuclear morphology contribute to disease progression. Therefore, if we understand the underlying mechanisms that lead to altered nuclear morphology and how they change cell behavior (for example, contribute to the ability of cancer cells to divide uncontrollably), then it may be possible to design new therapeutic and preventative strategies to combat disease.
Need for Further Study
This field is still in its infancy. Almost every area related to nuclear morphology needs further study.
- Nuclear envelope expansion in budding yeast is independent of cell growth and does not determine nuclear volume.
- Walters AD, Amoateng K, Wang R, Chen JH, McDermott G, Larabell CA, Gadal O, Cohen-Fix O.
- Mol Biol Cell (2019 Jan 1) 30:131-145. Abstract/Full Text
- Live-imaging analysis of germ cell proliferation in the C. elegans adult supports a stochastic model for stem cell proliferation.
- Rosu S, Cohen-Fix O.
- Dev Biol (2017 Mar 15) 423:93-100. Abstract/Full Text
Research in Plain Language
The main research focus of my lab is the relationship between nuclear structure and nuclear function. Altered nuclear shape is observed in certain types of diseases, such as cancer and during aging. However, the relationship between changes to nuclear morphology and either disease state or aging is unknown. We use budding yeast and C. elegans, two very powerful genetic systems, to identify genes that, when mutated, lead to abnormal nuclear shape. We are currently studying two main aspects of nuclear morphology: (1) what determines nuclear size and (2) how is the nuclear envelope remodeled to allow mixing of the maternal and paternal genomes after fertilization.